These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10667239)

  • 21. Synthesis and cytotoxicity evaluation of substituted pyridazino[4,5-b]phenazine-5,12-diones and tri/tetra-azabenzofluorene-5,6-diones.
    Lee HJ; Kim JS; Suh ME; Park HJ; Lee SK; Rhee HK; Kim HJ; Seo EK; Kim C; Lee CO; Park Choo HY
    Eur J Med Chem; 2007 Feb; 42(2):168-74. PubMed ID: 17070967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New phenazine analogues from Streptomyces sp. IFM 11694 with TRAIL resistance-overcoming activities.
    Abdelfattah MS; Ishikawa N; Karmakar UK; Yamaku K; Ishibashi M
    J Antibiot (Tokyo); 2016 Jun; 69(6):446-50. PubMed ID: 26669750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
    Merlin JL; Marchal S; Ramacci C; Lucas C; Paraire M; Poullain MG
    Bull Cancer; 1994 Oct; 81(10):906-9. PubMed ID: 7734778
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on antitumor activity of phenazine derivatives against S 180 in mice. (VI).
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):171-4. PubMed ID: 5616567
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on antitumor activity of phenazine derivatives against S 180 in mice. (IV).
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):164-8. PubMed ID: 5616565
    [No Abstract]   [Full Text] [Related]  

  • 26. Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190.
    Samata K; Yamagishi T; Ichihara T; Nanaumi K; Ikeda T; Ikeya H; Kuraishi A; Nakaike S; Kashiwagi K; Igarashi K
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):367-72. PubMed ID: 12439594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on antitumor activity of phenazine derivatives against S 180 in mice. (V). On iodinin and its isomers.
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):169-70. PubMed ID: 5616566
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on antitumor activity of phenazine derivatives against S 180 in mice. (VII). On phenazinequinone derivatives.
    Endo H; Tada M; Katagiri K
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):175-6. PubMed ID: 5616568
    [No Abstract]   [Full Text] [Related]  

  • 30. Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.
    Lu Y; Yan Y; Wang L; Wang X; Gao J; Xi T; Wang Z; Jiang F
    Eur J Med Chem; 2017 Feb; 127():928-943. PubMed ID: 27836197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
    Bennis S; Robert J
    Bull Cancer; 1994 Oct; 81(10):886-90. PubMed ID: 7734772
    [No Abstract]   [Full Text] [Related]  

  • 32. D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.
    Bacher G; Nickel B; Emig P; Vanhoefer U; Seeber S; Shandra A; Klenner T; Beckers T
    Cancer Res; 2001 Jan; 61(1):392-9. PubMed ID: 11196193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
    Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
    Top Curr Chem (Cham); 2019 May; 377(3):15. PubMed ID: 31073777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.
    Shack S; Miller A; Liu L; Prasanna P; Thibault A; Samid D
    Clin Cancer Res; 1996 May; 2(5):865-72. PubMed ID: 9816242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
    Cheng G; Li Y; Tian F
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
    Li S; Lei Y; Jia Y; Li N; Wink M; Ma Y
    Phytomedicine; 2011 Dec; 19(1):83-7. PubMed ID: 21802927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.
    Cocker HA; Tiffin N; Pritchard-Jones K; Pinkerton CR; Kelland LR
    Clin Cancer Res; 2001 Oct; 7(10):3193-8. PubMed ID: 11595714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.